Dabeeran Zehra1, Zahida Memon1, Shumaila Usman2,*, Almas Jabeen3, Kauser Ismail1 and Rehan Ahmed Siddiqui2
Jiangbo Shao1, Donglai Zhu2, Shengqiang Zou1, Guohong Ge1 and Ju Huang1*
...asing sensitivity to the sorafenib therapy in hepatocellular carcinoma. In this study, the potential functions and mechanisms of SOX9 in promoting hepatocellular carcinoma progression were investigated through comprehensive bioinformatics analysis. We found that SOX9 mainly participated in heat stress response, protein folding as well as metabolism and biosynthesis of amino acid. SOX9 correlated with HSPA1B were negative to the progression in hepatocellular ca...
Hend A. Hamedo, Ahmed E.M. Shokr, Omnia T. Abd-Elsalam and Naglaa Elshafey*
... of PHAs ingredients and sorafenib drug against HCC, showing a promising binding affinity ranging from 20.2 to 23.2 kcal/ mol. Our findings indicate that Paracoccus onubensis strain E3 is a promising candidate for producing PHAs, which could be used as a drug delivery system for HCC treatment with sorafenib drug....
